350 related articles for article (PubMed ID: 31092922)
1. Targeting the CBM complex causes T
Di Pilato M; Kim EY; Cadilha BL; Prüßmann JN; Nasrallah MN; Seruggia D; Usmani SM; Misale S; Zappulli V; Carrizosa E; Mani V; Ligorio M; Warner RD; Medoff BD; Marangoni F; Villani AC; Mempel TR
Nature; 2019 Jun; 570(7759):112-116. PubMed ID: 31092922
[TBL] [Abstract][Full Text] [Related]
2. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
[TBL] [Abstract][Full Text] [Related]
3. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells.
Molinero LL; Yang J; Gajewski T; Abraham C; Farrar MA; Alegre ML
J Immunol; 2009 Jun; 182(11):6736-43. PubMed ID: 19454668
[TBL] [Abstract][Full Text] [Related]
4. Bcl10 is required for the development and suppressive function of Foxp3
Yang D; Zhao X; Lin X
Cell Mol Immunol; 2021 Jan; 18(1):206-218. PubMed ID: 31595055
[TBL] [Abstract][Full Text] [Related]
5. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
6. A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.
Yin H; Karayel O; Chao YY; Seeholzer T; Hamp I; Plettenburg O; Gehring T; Zielinski C; Mann M; Krappmann D
Cell Mol Life Sci; 2022 Jan; 79(2):112. PubMed ID: 35099607
[TBL] [Abstract][Full Text] [Related]
7. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
David L; Li Y; Ma J; Garner E; Zhang X; Wu H
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
9. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
[TBL] [Abstract][Full Text] [Related]
10. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
[TBL] [Abstract][Full Text] [Related]
11. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
[TBL] [Abstract][Full Text] [Related]
12. CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade.
Drerup JM; Deng Y; Pandeswara SL; Padrón ÁS; Reyes RM; Zhang X; Mendez J; Liu A; Clark CA; Chen W; Conejo-Garcia JR; Hurez V; Gupta H; Curiel TJ
Cancer Res; 2020 Nov; 80(22):5063-5075. PubMed ID: 32948605
[TBL] [Abstract][Full Text] [Related]
13. Molecular architecture and regulation of BCL10-MALT1 filaments.
Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
[TBL] [Abstract][Full Text] [Related]
14. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
Front Immunol; 2018; 9():2078. PubMed ID: 30283440
[TBL] [Abstract][Full Text] [Related]
15. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
[TBL] [Abstract][Full Text] [Related]
16. Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy.
Zhulai G; Oleinik E
Scand J Immunol; 2022 Mar; 95(3):e13129. PubMed ID: 34936125
[TBL] [Abstract][Full Text] [Related]
17. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
[TBL] [Abstract][Full Text] [Related]
18. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
19. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
Front Immunol; 2018; 9():1136. PubMed ID: 29881386
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance to cancer can be abrogated by T regulatory cell inhibition.
Whelan MC; Casey G; Larkin JO; Guinn BA; O'Sullivan GC; Tangney M
PLoS One; 2014; 9(5):e97602. PubMed ID: 24832130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
